But the risks are proportionate: customer deferrals, European slowdown, and the inherent uncertainty of moving from pilot to commercial scale
As described before, the exendin-4 peptide acts as an agonist on the GLP-1R, thus not only binding it, but also inducing increased insulin release
Per the 8-K the acquired assets include: AI Drug Discovery Platform: A patented system that uses artificial intelligence (AI) to design 3D models of epitopes to facilitate the creation of better antibody drug candidates
Deragon MA, McCaig WD, Patel PS, Haluska RJ, Hodges AL, Sosunov SA, et al
Panneerselvam, S
with more than this amount, there is a risk of toxicity (Lim, 2023)